J.B.A.G. Haanen

838 citations
33 papers · 468 indexed · 1 hit paper · h-index 11
Topics
Cancer Immunotherapy and Biomarkers (12 papers)Melanoma and MAPK Pathways (11 papers)CAR-T cell therapy research (6 papers)
Partner nations
NetherlandsGermanyItaly

In The Last Decade

J.B.A.G. Haanen

28 papers receiving 458 citations

Hit Papers

LBA7 Neoadjuvant immune checkpoint inhibition in locally ...202220262023202420224080120

Peers

J.B.A.G. Haanen
Comparison fields: 5 of 63
  • Oncology 386
  • Immunology 165
  • Molecular Biology 99
  • Pathology and Forensic Medicine 98
  • Surgery 70
Replace Christine Marie Dela Cruz with:
Christine Marie Dela Cruz United States
Raya Mawad United States
Meagan S. Barbee United States
Tuan S. Nguyen United States
Shari Thomas United States
Ashwin R. Sama United States
Seshadri Thirumala United States
Philip He United States
Macdonald Js United States
Amy Musiek United States
J.B.A.G. Haanen relative to Christine Marie Dela Cruz United States Christine Marie Dela Cruz's profile →
Citations per field
00.5×5.8×
Christine Marie Dela Cruz · 1×
Citations per year

Countries citing papers authored by J.B.A.G. Haanen

Since Specialization
Citations

This map shows the geographic impact of J.B.A.G. Haanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.B.A.G. Haanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.B.A.G. Haanen more than expected).

Fields of papers citing papers by J.B.A.G. Haanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.B.A.G. Haanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.B.A.G. Haanen. The network helps show where J.B.A.G. Haanen may publish in the future.

Co-authorship network of co-authors of J.B.A.G. Haanen

This figure shows the co-authorship network connecting the top 25 collaborators of J.B.A.G. Haanen. A scholar is included among the top collaborators of J.B.A.G. Haanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.B.A.G. Haanen. J.B.A.G. Haanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 11
5 0
6 16
7 0
8
LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 studybreakdown →
129
9 2
10 6
11 3
12 10
13 11
14 1
15 46
16 18
17 6
18 1
19 0
20 22

About J.B.A.G. Haanen

J.B.A.G. Haanen is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 33 papers that have together received 468 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Melanoma and MAPK Pathways (11 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Oncology (386 citations), Immunology (165 citations) and Pathology and Forensic Medicine (98 citations). J.B.A.G. Haanen has collaborated with scholars based in Netherlands, Germany and Italy. Frequent co-authors include Axel Hauschild, Jesús Gómez-Navarro, Richard Kefford, C.J.A. Punt, Claus Garbe, Dmitri Pavlov, A. Ribas, Michiel C.T. van Zeijl, Michel W.J.M. Wouters and Steven J. Oosterling. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026